Target intelligence / Profile preview

Chitin synthase 1 (CHS1) (CHS1)

Target
CHS1
Molecular classification
Enzyme, Glycosyltransferase
01

Overview

Chitin synthase 1 (CHS1) is the key enzyme within the chitin synthesis machinery of ectoparasites such as the cat flea, Ctenocephalides felis (UniProt, https://www.uniprot.org/uniprotkb/Q9GNY0/entry). It is responsible for the polymerization of N-acetylglucosamine into chitin, which provides structural integrity to the insect's exoskeleton and the protective shell of its eggs (NCBI, https://pubmed.ncbi.nlm.nih.gov/8829700/). In the life cycle of the flea, this machinery is particularly vital during embryogenesis and the molting of larvae, where rapid chitin deposition is required. Drugs like lufenuron target this process by inhibiting the synthesis and assembly of chitin fibers, leading to eggs that fail to hatch and larvae that cannot survive the transition to the next developmental stage (PubChem, https://pubchem.ncbi.nlm.nih.gov/compound/Lufenuron). Because chitin is absent in vertebrate biology, CHS1 serves as a highly selective target for veterinary ectoparasiticides with minimal risk to the host (VCA Animal Hospitals, https://vcahospitals.com/know-your-pet/flea-control-lufenuron). However, these agents are typically not adulticidal, meaning they control flea populations by breaking the reproductive cycle rather than killing existing adult fleas on the animal. This mechanism is essential for long-term management of infestations and the prevention of flea-associated conditions like flea allergy dermatitis. The specificity of this target ensures that the drugs do not interfere with the metabolic processes of the treated pets.

Other names
Chitin synthaseChitin synthetaseUDP-N-acetyl-D-glucosamine:chitin 4-beta-N-acetylglucosaminyltransferaseParasite chitin synthesis machineryInsect development inhibitor target
02

Mechanism of action

Inhibition of chitin polymerization and deposition during cuticle and eggshell formation (PubChem, https://pubchem.ncbi.nlm.nih.gov/compound/Lufenuron; ScienceDirect, https://www.sciencedirect.com/topics/agricultural-and-biological-sciences/chitin-synthesis-inhibitor)

03

Biological functions

Chitin biosynthesisCuticle formationMoltingEmbryogenesis
04

Disease associations

InfectionEctoparasitic infestationFlea allergy dermatitis
05

Safety considerations

Environmental toxicity to aquatic invertebrates (PubChem, https://pubchem.ncbi.nlm.nih.gov/compound/Lufenuron)Lack of adulticidal activityPotential impact on non-target arthropods
06

Interacting drugs

Lufenuron

3 more in the full profile.

07

Biomarkers

Egg hatchabilityLarval survival rateChitin content in cuticle

Beyond the preview

Go deeper on Chitin synthase 1 (CHS1) (CHS1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Chitin synthase 1 (CHS1) (CHS1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call